esrp, a premier commercial real estate brokerage focused on tenant advisory services, has secured a long-term 114,500 square foot office lease for Caris Life Sciences in Irving, Texas.
Caris Life Sciences is a leading innovator in molecular science. The Caris Life Sciences Corporate Park in Irvingwill welcome a new R&D laboratory and office space, and create more than 500 new job opportunities. Located at Royal 10 Office Center at 3600 Royal Lane, the new facilitywill support the company’s continued growth and focus on fulfilling the promise of precision medicine.
“We are pleased to partner with esrp – they consistently look after our best interest and provide solutions to assist in our strategic expansion,” said Michael Halbert, Senior Vice President of Human Resources at Caris Life Sciences. “This new facility will enable us to substantially expand the company’s offerings, as we work to reinvent cancer care.
The property is owned by a Fund managed by Kawa Capital Partners, dedicated to long-term leased real estate for high-quality corporates. Greg Burns and Christopher Schafer, ESQ of esrp represented the tenant in lease negotiations with the developer, Myers & Crow Company, and Kawa.
“It is a privilege to serve an innovative company like Caris Life Sciences in their continued strategic facility expansion to accommodate the growth of their workforce in the metroplex, and as they passionately pursue life-changing advances in cancer care.” said Greg Burns, Executive Vice President of Tenant Advisory Services at esrp.
About esrp
esrp is a tenant and buyer focused commercial real estate company based in Dallas/Fort Worth, assisting clients in over 40 countries.
In an industry where conflicts of interest are common, esrp is different. Unlike most commercial real estate firms, esrp never attempts to represent both sides of a transaction. We don’t lease, own, or manage properties. We only represent tenants and buyers, never landlords. There is never a conflict of interest. esrp simply represent tenants. All day, every day.
About Caris Life Sciences
Caris Life Sciences® is a leading innovator in molecular science focused on fulfilling the promise of precision medicine through quality and innovation. The company's suite of market-leading molecular profiling offerings assess DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make more precise and personalized treatment decisions. Caris is also advancing precision medicine with Next Generation Profiling™ that combines its innovative service offerings, Caris Molecular Intelligence® and ADAPT Biotargeting System™, with its proprietary artificial intelligence analytics engine, DEAN™, to analyze the whole exome, whole transcriptome and complete cancer proteome. This information, coupled with mature clinical outcomes on thousands of patients, provides unmatched molecular solutions for patients, physicians, payers and biopharmaceutical organizations. Headquartered in Irving, Texas, Caris Life Sciences offers services throughout the U.S., Europe, Asia and other international markets.
To learn more, visit www.CarisLifeSciences.com or follow on Twitter @CarisLS
